[Primary body cavity lymphoma: a new clinico-pathologic entity]
- PMID: 9499149
[Primary body cavity lymphoma: a new clinico-pathologic entity]
Similar articles
-
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.Cancer Res. 1998 Jul 15;58(14):3051-8. Cancer Res. 1998. PMID: 9679970
-
The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.Neoplasma. 1998;45(2):88-95. Neoplasma. 1998. PMID: 9687889
-
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].Ai Zheng. 2007 Apr;26(4):418-22. Ai Zheng. 2007. PMID: 17430665 Chinese.
-
DCs in lymphoma--biology and therapeutic aspects.Cytotherapy. 2004;6(2):138-47. doi: 10.1080/14653240410006095. Cytotherapy. 2004. PMID: 15203990 Review. No abstract available.
-
The role of immunohistochemistry in the diagnosis of cutaneous lymphoma.Adv Dermatol. 1997;13:207-34. Adv Dermatol. 1997. PMID: 9551145 Review. No abstract available.
Cited by
-
Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient.Clin Diagn Lab Immunol. 2001 Sep;8(5):993-6. doi: 10.1128/CDLI.8.5.993-996.2001. Clin Diagn Lab Immunol. 2001. PMID: 11527816 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical